ANI Pharmaceuticals, Inc. Insider Transactions
ANI Pharmaceuticals, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $63.80 | $15,950 | 59,231 | 06/13/2024 | 06/14/2024 | |
Gutwerg Ori
SVP, GENERICS |
Sell | 2,985 @ $67.00 | $199,995 | 77,227 | 06/05/2024 | 06/06/2024 | |
CAREY STEPHEN P.
SVP & CFO |
Sell | 5,000 @ $63.58 | $317,900 | 161,968 | 06/04/2024 | 06/06/2024 | |
Gassert Chad
SVP - CORP. DEV. & STRATEGY |
Sell | 20,000 @ $64.41 | $1.29 M | 213,226 | 06/03/2024 | 06/04/2024 | |
Mutz Christopher
HEAD OF RARE DISEASE |
Sell | 2,000 @ $61.61 | $123,220 | 83,277 | 05/21/2024 | 05/22/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 12,855 @ $61.81 | $794,568 | 732,620 | 05/20/2024 | 05/21/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 5,836 @ $62.09 | $362,357 | 745,475 | 05/17/2024 | 05/17/2024 | |
TANNENBAUM RENEE P
Director |
Sell | 2,000 @ $63.87 | $127,740 | 18,211 | 05/16/2024 | 05/17/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 16,459 @ $63.84 | $1.05 M | 751,311 | 05/16/2024 | 05/17/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 14,850 @ $65.86 | $978,021 | 767,770 | 05/15/2024 | 05/17/2024 | |
Lalwani Nikhil
CEO |
Sell | 16,669 @ $66.10 | $1.10 M | 377,505 | 05/14/2024 | 05/16/2024 | |
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $67.69 | $16,923 | 59,481 | 05/13/2024 | 05/13/2024 | |
Gassert Chad
SVP - CORP. DEV. & STRATEGY |
Sell | 20,000 @ $66.62 | $1.33 M | 233,226 | 05/01/2024 | 05/03/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 16,809 @ $65.17 | $1.10 M | 782,620 | 04/19/2024 | 04/22/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 10,423 @ $64.98 | $677,287 | 799,429 | 04/18/2024 | 04/22/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 9,520 @ $65.40 | $622,608 | 809,852 | 04/17/2024 | 04/17/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 5,834 @ $66.20 | $386,211 | 819,372 | 04/16/2024 | 04/17/2024 | |
Shanmugam Muthusamy
Director, HEAD OF R&D, COO-NOVITIUM OPS |
Sell | 7,414 @ $66.33 | $491,771 | 825,206 | 04/15/2024 | 04/17/2024 | |
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC. |
Sell | 250 @ $67.79 | $16,948 | 59,731 | 04/12/2024 | 04/15/2024 | |
Gassert Chad
SVP - CORP. DEV. & STRATEGY |
Sell | 20,000 @ $67.25 | $1.35 M | 253,226 | 04/01/2024 | 04/02/2024 |
ANI Pharmaceuticals, Inc. FAQ's
The list of insiders at ANI Pharmaceuticals, Inc. includes Pera Antonio R, Shanmugam Muthusamy, Mutz Christopher, Lalwani Nikhil, Marken James G., Gassert Chad, CAREY STEPHEN P., Cook Meredith, TANNENBAUM RENEE P, Gutwerg Ori, Davis Krista.
Insiders have sold a total of 519,017 ANI Pharmaceuticals, Inc. shares in the last 12 months for a total of 33.21 M sold.
The following insiders have sold ANI Pharmaceuticals, Inc. shares in the last 12 months: Pera Antonio R ($456,400), Shanmugam Muthusamy ($15.94 M), Mutz Christopher ($828,270), Lalwani Nikhil ($6.03 M), Marken James G. ($1.62 M), Gassert Chad ($6.55 M), CAREY STEPHEN P. ($1.25 M), Cook Meredith ($155,490), TANNENBAUM RENEE P ($127,740), Gutwerg Ori ($199,995), Davis Krista ($60,000),